In humans, Bhlhe22 has been identified as a highly methylated gene in endometrial cancer with potential epigenetic biomarkers in cervical scrapings (Liew et al., 2019), while Bhlhe23 has been linked to mammalian retinal development (Woods et al., 2018). The gene discussed is BHLHE23; the disease is endometrial cancer.